CDTRP 2024 Research Connect Series

The CDTRP Research Connect series is taking place every other Tuesday at 3 pm ET. Don’t forget to mark your calendars for this engaging series!

This series streamlines the subset of Theme, Hub, and Working Group meetings that aimed to share and discuss the latest research findings across the network and our Webinar series, which featured national and international speakers. Theme, Hub, and Working Group meetings aimed at developing new initiatives, projects, or grants will be scheduled separately, approximately three times per year per group. Our goal is to make it easy for our members to know about and attend high quality presentations across all Themes and topics of interest. We are aiming for active discussions including researchers, trainees, and patient, family, and donor partners, engaging the whole community as if we were having a family dinner rather than listening to a formal presentation.

On May 14, 2024 we are please to have Dr. Victor Ferreira, present on the topic:
Vaccine chronicles: characterizing immune responses in transplant recipients through the COVID-19 Pandemic – Theme 4

About Dr. Victor Ferreira

Dr. Victor Ferreira is an Assistant Scientist in the Ajmera Transplant Centre at the University Health Network (UHN) and the Toronto General Hospital Research Institute (TGHRI). He is also an Assistant Professor at the University of Toronto in the Department of Laboratory Medicine and Pathobiology (LMP). He completed his PhD in Medical Sciences – Infection and Immunity Specialization at McMaster University in 2014 and post-doctoral training at UHN. His research program is focused on three pillars: I) using systems vaccinology to reveal insights into vaccine responses in immunocompromised individuals like transplant recipients; II) characterizing the impact of chronic viral infection on host immune responses; and III) developing novel methods for eliminating latent viruses in human organs. His work has been cited >2,500 times and is published in journals including the New England Journal of Medicine, Nature Immunology, the Lancet Infectious Diseases, Clinical Infectious Diseases, the American Journal of Transplantation and Journal of Infectious Diseases.